Qingdao Net Income vs Capital Expenditures Analysis

688139 Stock

33.28 0.36 1.09%

Qingdao Haier financial indicator trend analysis is much more than just breaking down Qingdao Haier Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Qingdao Haier Biomedical is a good investment. Please check the relationship between Qingdao Haier Net Income and its Capital Expenditures accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Qingdao Haier Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Net Income vs Capital Expenditures

Net Income vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Qingdao Haier Biomedical Net Income account and Capital Expenditures. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Qingdao Haier's Net Income and Capital Expenditures is 0.83. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Qingdao Haier Biomedical, assuming nothing else is changed. The correlation between historical values of Qingdao Haier's Net Income and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Qingdao Haier Biomedical are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Net Income i.e., Qingdao Haier's Net Income and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.83

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Qingdao Haier Biomedical financial statement analysis. It represents the amount of money remaining after all of Qingdao Haier Biomedical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Capital Expenditures

Capital Expenditures are funds used by Qingdao Haier Biomedical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Qingdao Haier operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Qingdao Haier's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Qingdao Haier Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Qingdao Haier Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of November 30, 2024, Tax Provision is expected to decline to about 21.3 M. In addition to that, Selling General Administrative is expected to decline to about 263.1 M

	2021	2022	2023	2024 (projected)
Gross Profit	1.1B	1.4B	1.2B	806.0M
Total Revenue	2.1B	2.9B	2.3B	1.6B

Gross Profit Total Revenue

Qingdao Haier fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Non Current Liabilities Other	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.23	0.88	0.99	0.91	0.97	0.83	0.93	0.8	0.86	0.59	0.94	0.6	0.86	0.96	0.95	0.63	0.84	0.91	-0.8	0.02	0.95	0.25	0.9	0.96	0.95
Other Current Liab	0.23		0.37	0.21	0.08	0.24	-0.1	0.32	0.31	-0.06	-0.27	0.42	0.27	-0.02	0.21	0.46	-0.07	-0.02	0.36	-0.52	-0.06	0.37	-0.35	0.07	0.25	0.15
Total Current Liabilities	0.88	0.37		0.81	0.75	0.78	0.63	0.98	0.69	0.71	0.43	0.85	0.8	0.71	0.79	0.84	0.5	0.68	1.0	-0.7	0.4	0.91	0.05	0.76	0.84	0.79
Total Stockholder Equity	0.99	0.21	0.81		0.91	0.99	0.85	0.89	0.81	0.86	0.6	0.93	0.52	0.85	0.97	0.94	0.64	0.84	0.85	-0.81	-0.08	0.93	0.28	0.89	0.96	0.95
Other Liab	0.91	0.08	0.75	0.91		0.85	0.95	0.82	0.74	0.97	0.79	0.87	0.47	0.98	0.93	0.88	0.77	0.9	0.79	-0.7	-0.16	0.83	0.32	0.99	0.86	0.97
Net Tangible Assets	0.97	0.24	0.78	0.99	0.85		0.78	0.86	0.82	0.79	0.54	0.92	0.5	0.78	0.93	0.92	0.61	0.79	0.82	-0.84	-0.07	0.92	0.2	0.82	0.97	0.91
Retained Earnings	0.83	-0.1	0.63	0.85	0.95	0.78		0.69	0.51	0.96	0.83	0.72	0.36	0.96	0.86	0.79	0.74	0.97	0.68	-0.52	-0.2	0.72	0.47	0.96	0.73	0.91
Accounts Payable	0.93	0.32	0.98	0.89	0.82	0.86	0.69		0.79	0.76	0.46	0.9	0.71	0.76	0.87	0.89	0.51	0.71	0.99	-0.77	0.29	0.95	0.14	0.81	0.9	0.86
Cash	0.8	0.31	0.69	0.81	0.74	0.82	0.51	0.79		0.66	0.42	0.88	0.51	0.65	0.76	0.75	0.57	0.46	0.72	-0.9	-0.05	0.81	-0.07	0.67	0.91	0.78
Non Current Assets Total	0.86	-0.06	0.71	0.86	0.97	0.79	0.96	0.76	0.66		0.9	0.79	0.52	0.99	0.84	0.79	0.87	0.93	0.74	-0.6	-0.08	0.75	0.25	0.98	0.81	0.95
Non Currrent Assets Other	0.59	-0.27	0.43	0.6	0.79	0.54	0.83	0.46	0.42	0.9		0.52	0.41	0.87	0.56	0.49	0.95	0.82	0.46	-0.34	-0.09	0.43	0.07	0.81	0.58	0.76
Other Assets	0.94	0.42	0.85	0.93	0.87	0.92	0.72	0.9	0.88	0.79	0.52		0.63	0.81	0.94	0.94	0.6	0.69	0.88	-0.84	-0.05	0.9	0.11	0.85	0.93	0.88
Net Receivables	0.6	0.27	0.8	0.52	0.47	0.5	0.36	0.71	0.51	0.52	0.41	0.63		0.48	0.44	0.49	0.54	0.45	0.78	-0.46	0.49	0.61	-0.26	0.5	0.61	0.53
Good Will	0.86	-0.02	0.71	0.85	0.98	0.78	0.96	0.76	0.65	0.99	0.87	0.81	0.48		0.87	0.81	0.82	0.91	0.75	-0.59	-0.12	0.74	0.3	0.99	0.79	0.94
Non Current Liabilities Total	0.96	0.21	0.79	0.97	0.93	0.93	0.86	0.87	0.76	0.84	0.56	0.94	0.44	0.87		0.95	0.55	0.81	0.83	-0.73	-0.16	0.88	0.41	0.91	0.89	0.91
Inventory	0.95	0.46	0.84	0.94	0.88	0.92	0.79	0.89	0.75	0.79	0.49	0.94	0.49	0.81	0.95		0.53	0.8	0.88	-0.82	-0.11	0.93	0.25	0.87	0.88	0.91
Other Current Assets	0.63	-0.07	0.5	0.64	0.77	0.61	0.74	0.51	0.57	0.87	0.95	0.6	0.54	0.82	0.55	0.53		0.75	0.51	-0.54	-0.05	0.52	-0.17	0.77	0.68	0.79
Other Stockholder Equity	0.84	-0.02	0.68	0.84	0.9	0.79	0.97	0.71	0.46	0.93	0.82	0.69	0.45	0.91	0.81	0.8	0.75		0.72	-0.54	-0.09	0.75	0.37	0.92	0.73	0.91
Total Liab	0.91	0.36	1.0	0.85	0.79	0.82	0.68	0.99	0.72	0.74	0.46	0.88	0.78	0.75	0.83	0.88	0.51	0.72		-0.72	0.34	0.93	0.1	0.8	0.86	0.83
Deferred Long Term Liab	-0.8	-0.52	-0.7	-0.81	-0.7	-0.84	-0.52	-0.77	-0.9	-0.6	-0.34	-0.84	-0.46	-0.59	-0.73	-0.82	-0.54	-0.54	-0.72		0.11	-0.88	0.11	-0.63	-0.89	-0.81
Short Long Term Debt	0.02	-0.06	0.4	-0.08	-0.16	-0.07	-0.2	0.29	-0.05	-0.08	-0.09	-0.05	0.49	-0.12	-0.16	-0.11	-0.05	-0.09	0.34	0.11		0.09	-0.38	-0.12	0.06	-0.1
Total Current Assets	0.95	0.37	0.91	0.93	0.83	0.92	0.72	0.95	0.81	0.75	0.43	0.9	0.61	0.74	0.88	0.93	0.52	0.75	0.93	-0.88	0.09		0.18	0.8	0.94	0.9
Non Current Liabilities Other	0.25	-0.35	0.05	0.28	0.32	0.2	0.47	0.14	-0.07	0.25	0.07	0.11	-0.26	0.3	0.41	0.25	-0.17	0.37	0.1	0.11	-0.38	0.18		0.33	0.04	0.22
Intangible Assets	0.9	0.07	0.76	0.89	0.99	0.82	0.96	0.81	0.67	0.98	0.81	0.85	0.5	0.99	0.91	0.87	0.77	0.92	0.8	-0.63	-0.12	0.8	0.33		0.82	0.95
Common Stock	0.96	0.25	0.84	0.96	0.86	0.97	0.73	0.9	0.91	0.81	0.58	0.93	0.61	0.79	0.89	0.88	0.68	0.73	0.86	-0.89	0.06	0.94	0.04	0.82		0.93
Property Plant Equipment	0.95	0.15	0.79	0.95	0.97	0.91	0.91	0.86	0.78	0.95	0.76	0.88	0.53	0.94	0.91	0.91	0.79	0.91	0.83	-0.81	-0.1	0.9	0.22	0.95	0.93

Click cells to compare fundamentals

Qingdao Haier Account Relationship Matchups

Qingdao Haier fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.0B	3.9B	4.9B	5.5B	5.5B	3.7B
Other Current Liab	171.7M	386.9M	514.2M	14.4M	8.7M	8.3M
Total Current Liabilities	545.8M	1.0B	1.1B	1.2B	941.7M	929.4M
Total Stockholder Equity	2.5B	2.8B	3.6B	4.0B	4.2B	2.7B
Other Liab	35.3M	113.7M	113.3M	145.5M	167.3M	175.7M
Net Tangible Assets	1.1B	2.4B	2.2B	3.1B	3.5B	1.8B
Retained Earnings	260.4M	584.3M	1.3B	1.8B	1.9B	1.9B
Accounts Payable	259.8M	448.1M	431.6M	485.1M	391.0M	366.3M
Cash	1.4B	1.8B	774.4M	951.8M	1.3B	949.4M
Non Current Assets Total	478.5M	1.2B	1.4B	2.0B	3.0B	3.1B
Non Currrent Assets Other	16.2M	16.9M	120.4M	151.3M	853.9M	896.6M
Other Assets	24.8M	37.6M	65.4M	55.5M	63.8M	42.2M
Net Receivables	135.7M	135.0M	112.3M	155.8M	187.7M	167.2M
Good Will	15.5M	323.9M	323.5M	451.3M	642.7M	674.8M
Non Current Liabilities Total	35.3M	113.7M	117.6M	156.2M	144.1M	80.3M
Inventory	105.6M	247.9M	345.7M	270.5M	248.0M	187.3M
Other Current Assets	51.1M	25.4M	38.2M	8.2M	132.8M	139.4M
Other Stockholder Equity	5.7M	6.1M	(1.0M)	84.3M	97.0M	101.8M
Total Liab	581.1M	1.2B	1.3B	1.3B	1.1B	1.0B
Deferred Long Term Liab	169.4K	1.3M	502.3K	5.5M	4.9M	4.2M
Short Long Term Debt	4.6M	31.8M	9.9M	25.2M	20.8M	19.8M
Total Current Assets	2.6B	2.7B	3.5B	3.5B	2.5B	2.6B
Non Current Liabilities Other	3.6M	6.0M	7.3M	18.8M	7.1M	8.1M
Intangible Assets	9.1M	214.6M	241.6M	312.3M	367.7M	386.1M
Property Plant Equipment	112.1M	294.7M	343.6M	464.1M	533.8M	560.4M
Net Invested Capital	2.5B	2.8B	3.6B	4.0B	4.3B	3.1B
Net Working Capital	2.0B	1.7B	2.3B	2.3B	1.6B	1.8B

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Qingdao Stock

Balance Sheet is a snapshot of the financial position of Qingdao Haier Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Qingdao Haier Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Qingdao Haier and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Qingdao currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Qingdao Net Income vs Capital Expenditures Analysis

Net Income vs Capital Expenditures

Net Income vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Net Income

Capital Expenditures

Qingdao Haier fundamental ratios Correlations

Qingdao Haier Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Qingdao Haier fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Qingdao Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Total Stockholder Equity	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Intangible Assets	+ 0.99	Other Liab
Total Liab	+ 0.99	Accounts Payable
Good Will	+ 0.99	Non Current Assets Total

Deferred Long Term Liab	- 0.9	Cash
Common Stock	- 0.89	Deferred Long Term Liab
Total Current Assets	- 0.88	Deferred Long Term Liab
Deferred Long Term Liab	- 0.84	Other Assets
Deferred Long Term Liab	- 0.84	Net Tangible Assets
Deferred Long Term Liab	- 0.82	Inventory